List of Lab Research Products Companies in New York - 15

Amerigo is a distribution company providing essential supplies and services to the biomedical and life science research communities. Amerigo's founder has had more than 20 years of rich experience in the biomedical and biochemical fields and has established close contacts with key personnel in top international pharmaceutical and biotech companies, academic research institutes, and government research agencies. Amerigo's most valuable asset is a professional team, skilled at giving effective technical and customer support. Most of our employees own a graduate (Ph.D. or master) degree in life science, ready to understand customers' questions or concerns and provide individualized customer service with high standards. Our mission is to integrate premium product resources worldwide, simplify the search process for scientists, and provide the scientific community with the latest, professional solutions.

For over 30 years, Bionique Testing Laboratories has been a trusted partner and global leader of Mycoplasma Testing Services for the life science industry. Bionique offers the full breadth of GMP services from Lot & Final Drug Product Release Testing to Real-Time PCR assays. Our service portfolio and depth of expertise enables us to support our clients' needs from concept through clinical trials to commercialization for biopharmaceutical and cell therapy products. Our capabilities extend to successful method development and validation inclusive of rapid microbiological methods to generate real time results. Bionique stands ready to provide the highest quality of mycoplasma testing services to ensure the integrity and biosafety of your therapeutic products. Mycoplasma Testing Solutions for: • Cell and Gene Therapy Products • Clinical Trial Materials • Biopharmaceuticals • Master and Working Cell Banks • Raw Materials • Vaccines Bionique is a cGMP compliant, FDA-registered facility.

Caladan Bio is a Brooklyn-based startup specializing in next-generation bioreactors, offering modular, affordable, and cutting-edge solutions. The company's first product, the Caladan 250, is a high throughput benchtop bioreactor system that leverages AI and machine learning to enable advanced data capture and increase throughput. Caladan Bio is focused on revolutionizing the way biotechnology research is conducted by creating lower-cost, cutting-edge bioreactors and advanced software.

Clarapath is a medical robotics company automating the laboratory. Our first product is focused on automating the microtomy station in pathology. Our vision is to innovate, standardize, and digitally transform anatomic pathology through higher quality lab medicine, more robust safety standards, increased lab throughput, while lowering laboratory costs and labor related delays.

Curia is a Contract Development and Manufacturing Organization with over 30 years of experience, an integrated network of 25 global sites and 3,500 employees partnering with customers to make treatments broadly accessible to patients. Our biologics and small molecule offering spans discovery through commercialization, with integrated regulatory and analytical capabilities. Our scientific and process experts and state-of-the-art facilities deliver best-in-class experience across drug substance and drug product manufacturing. From curiosity to cure, we deliver every step to accelerate and sustain life-changing therapeutics. To learn more visit us at curiaglobal.com ************************************************** ⚠️NOTICE: Please Be Aware of False Employment Opportunities ************************************************** Please be aware there has been reported fraudulent activity within our industry regarding false offers being made to applicants and requests for personal information from individuals or organizations posing as company representatives. Any applicant who applies to Curia must submit their application through Curia’s career page at https://careers.curiaglobal.com. Applicants will only receive communication, including offer letters, from a curiaglobal.com email address. Please be aware that recent scams used email addresses that are similar to Curia addresses or use other public domain addresses such as gmail.com, yahoo.com and aol.com. Please confirm the sender’s email address prior to sharing your information.

For more than 45 years, Enzo Biochem has been a leader in innovation and product development to support a diverse range of needs in biomedical research and healthcare. With a comprehensive portfolio of 20,000 high-quality products including antibodies, genomic probes, assays, biochemicals, and proteins, Enzo supports the work of academic research centers and industry partners who are shaping the future of healthcare around the world. The company's proprietary products and technologies play central roles in all areas of translational research and drug development, including genomic analysis, protein analysis, cellular analysis, tissue analysis, and small molecule chemistry. Enzo Biochem has a broad and deep intellectual property port-folio, with patent coverage across a number of key enabling technologies.

At Epistemic AI we are building the next generation of tools to accelerate biomedical research with AI and NLP. We are a group of senior scientists and engineers from the likes of Google, New York University, Stanford and more. We are dedicated to enabling advances in biomedical research and practice with AI and NLP.

Matter Bio is a longevity holding company focused on preserving genome integrity As we age, our genome is constantly being damaged by exogenous and endogenous sources. Occasionally errors are missed and incorporated into the DNA in the form of mutations, structural variations, epigenetic drift, and other types of information loss. At Matter, we have assembled a world-class team of scientists and executives to help counter this critical information loss in the genome. To achieve this, we are focusing on a number of assets that address key stages in the genomic information loss continuum.

Nalge Nunc International is a distributor and manufacturer of plastic laboratory containers that has diversified into the field of containers for outdoor sports and packaging materials

NovaSterilis is the global leader in the development and manufacturing of supercritical carbon dioxide (scCO2) processes for biomaterials and medical devices, including the decellularization and sterilization of allograft and xenograft tissues. NovaSterilis' scCO2 technologies exceed the highest standards for product safety and performance. These processes have been used to treat ortho/dental/spinal products used in over 300,000 surgeries over the past 8 years. scCO2 involves lower temperatures (31°C) and pressure above 1100 psi. This lower temperature makes scCO2 ideal for materials that are temperature sensitive or reactive with other forms of sterilization. scCO2 can penetrate and sterilize delicate products and materials, such as allograft tissue, without damaging the product's structural or chemical integrity. NovaSterilis serves a variety of markets, including complex medical devices, drug delivery, tissue engineering, biotherapeutics/API, and additive manufacturing. With NovaSterilis, you can count on a sterility assurance level 10-6, an environmentally friendly solution, shorter turnaround times, and more. Protect and differentiate your products with supercritical CO2.

Overture Life is a clinical-stage biotechnology company whose mission is to automate assisted reproductive processes to improve IVF pregnancy outcomes through process automation and non-invasive embryo selection. Its revolutionary technologies help standardize fertility treatments, by simplifying techniques and optimizing resources to make reproductive technologies more affordable, reliable, and accessible. Founded by recognized global leaders in embryo genetic testing and assisted reproduction, Overture is backed by Khosla Ventures, Felicis Ventures, Octopus Ventures and GV, and maintains offices in the U.S. and Spain.

Our global associates are unified by a singular drive: to take on our customers’ biggest challenges. To solve the critical problems that stand in the way of advancing health, safety and the environment. Where others see something that can’t be done, we jump in fully committed to do it. We push the limits of science and technology. We redefine partnership through deeper, more meaningful collaboration. It’s how we’ve approached our calling since 1946. And why today you’ll find our filtration, separation and purification solutions at work in so many places. From life-saving gene therapies to airplane engines. Hydraulic systems to injectable medications. Scotch. Smartphones. OLED screens. Paper. Everyday Pall is there, helping protect critical operating assets, improve product quality, minimize emissions and waste, and safeguard health. No matter what, no matter where, we innovate and collaborate to deliver the one thing our customers need most: The unsolvable, solved. More here: http://www.pall.com. ******* Pall Corporation is proud to be part of Danaher. Danaher’s science and technology leadership puts Pall’s solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers. Together with Danaher’s other businesses across Biotechnology, Diagnostics and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day.

Scientific Industries, Inc, manufactures ALL the "GENIE" products in the USA. Equipment such as the well known VORTEX-GENIE, and other GENIE products used primarily for sample preparation and sample processing in the lab oratory market.r website www.scientificindustries.com to learn or find solutions to mixing, shaking, incubation for many types of samples.

SmartZyme is a life science company using PROVOLUTION™ , a proprietary technological platform for protein design and engineering, in accordance with industry required specifications. The company was founded in November 2013 by Shilo Ben Zeev (CEO) and David Baram, Ph.D. (CTO). The company aims to efficiently design and create proteins and potent enzymes with the specific characteristics required for optimal performance. Its products will be used to revolutionize industries by addressing unmet needs of various industrial fields. The company’s PROVOLUTION™ technology combines some of the most advanced scientific tools for protein engineering, computational biology and electrochemistry. These tools enable the development of improved, or “superior”, proteins and enzymes for wide ranging applications. The Company is currently focusing on the Diabetes market where it intends to launch its first two products: a pre-designed enzyme with superior characteristics for improved bio-electrochemical glucose catalysis, to be used on glucose test strips for the Self Monitoring Blood Glucose (SMBG) market. Strip manufacturers incorporating this superior enzyme in their products will be able to offer results which are far more accurate than current standard strips and ensure that their strips meet the rigid ISO 15197:2013 requirements. The company’s second product, the Go Patch Go™, personalized patient care system (PCS), an on-demand blood glucose measurement system in which measurement accuracy, enzyme stability and product shelf life are significantly enhanced due to the use of SmartZyme’s protein engineering technology. This product will offer diabetic patients a solution to current blood glucose monitoring systems which lack the optimal accuracy and stability required for effective treatment for diabetes. SmartZyme’s R&D efforts are supported by a scientific advisory board of leaders in the fields of protein engineering, structural biology and electrochemistry.